IRIDEX Net Income 2010-2024 | IRIX
IRIDEX net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
IRIDEX Annual Net Income
(Millions of US $) |
| 2023 |
$-10 |
| 2022 |
$-8 |
| 2021 |
$-5 |
| 2020 |
$-6 |
| 2019 |
$-9 |
| 2018 |
$-13 |
| 2017 |
$-13 |
| 2016 |
$-12 |
| 2015 |
$0 |
| 2014 |
$10 |
| 2013 |
$2 |
| 2012 |
$1 |
| 2011 |
$3 |
| 2010 |
$3 |
| 2009 |
$3 |
IRIDEX Quarterly Net Income
(Millions of US $) |
| 2024-09-30 |
$-2 |
| 2024-06-30 |
$-3 |
| 2024-03-31 |
$-3 |
| 2023-12-31 |
$-3 |
| 2023-09-30 |
$-2 |
| 2023-06-30 |
$-3 |
| 2023-03-31 |
$-2 |
| 2022-12-31 |
$-1 |
| 2022-09-30 |
$-2 |
| 2022-06-30 |
$-2 |
| 2022-03-31 |
$-2 |
| 2021-12-31 |
$-2 |
| 2021-09-30 |
$-2 |
| 2021-06-30 |
$1 |
| 2021-03-31 |
$-2 |
| 2020-12-31 |
$-0 |
| 2020-09-30 |
$-2 |
| 2020-06-30 |
$-3 |
| 2020-03-31 |
$-2 |
| 2019-12-31 |
$-2 |
| 2019-09-30 |
$-2 |
| 2019-06-30 |
$-2 |
| 2019-03-31 |
$-3 |
| 2018-12-31 |
$-3 |
| 2018-09-30 |
$-3 |
| 2018-06-30 |
$-3 |
| 2018-03-31 |
$-4 |
| 2017-12-31 |
$-5 |
| 2017-09-30 |
$-3 |
| 2017-06-30 |
$-3 |
| 2017-03-31 |
$-2 |
| 2016-12-31 |
$-11 |
| 2016-09-30 |
$-1 |
| 2016-06-30 |
$-0 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
$0 |
| 2015-09-30 |
$0 |
| 2015-06-30 |
$-1 |
| 2015-03-31 |
$0 |
| 2014-12-31 |
$9 |
| 2014-09-30 |
$0 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$0 |
| 2013-09-30 |
$1 |
| 2013-06-30 |
$0 |
| 2013-03-31 |
$1 |
| 2012-12-31 |
$0 |
| 2012-09-30 |
$-1 |
| 2012-06-30 |
$0 |
| 2012-03-31 |
$2 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$0 |
| 2011-06-30 |
$1 |
| 2011-03-31 |
$1 |
| 2010-12-31 |
$1 |
| 2010-09-30 |
$1 |
| 2010-06-30 |
$1 |
| 2010-03-31 |
$0 |
| 2009-12-31 |
$1 |
| 2009-09-30 |
$1 |
| 2009-06-30 |
$1 |
| 2009-03-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.028B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
